Core Insights - HealthEquity reported revenue of $322.16 million for the quarter ended October 2025, reflecting a year-over-year increase of 7.2% and exceeding the Zacks Consensus Estimate of $319.96 million by 0.69% [1] - The company's EPS for the quarter was $1.01, up from $0.78 in the same quarter last year, resulting in an EPS surprise of 12.22% compared to the consensus estimate of $0.90 [1] Financial Performance Metrics - Total HSA Assets reached $34.45 billion, surpassing the average estimate of $33.68 billion [4] - HSA investments amounted to $17.54 billion, exceeding the estimated $16.22 billion [4] - Total Accounts - CDBs were reported at 7.17 million, above the estimate of 7.05 million [4] - Total Accounts stood at 17.28 million, slightly above the average estimate of 17.26 million [4] - HSA cash assets were $16.91 billion, below the estimated $17.43 billion [4] - Total Accounts - HSAs reached 10.11 million, slightly below the estimate of 10.21 million [4] - Revenue from Services was $120.29 million, slightly above the estimate of $119.5 million, marking a year-over-year increase of 0.9% [4] - Custodial Revenue was reported at $159.07 million, exceeding the estimate of $156.61 million, with a year-over-year change of 12.9% [4] - Interchange Revenue was $42.81 million, slightly below the estimate of $42.88 million, reflecting a year-over-year increase of 6.2% [4] Stock Performance - HealthEquity's shares have returned 4.1% over the past month, contrasting with a -0.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates